<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01126931</url>
  </required_header>
  <id_info>
    <org_study_id>Appetite and Weight Loss</org_study_id>
    <nct_id>NCT01126931</nct_id>
  </id_info>
  <brief_title>Wormwood in Chronic Progressive Disorders With Reduced Appetite</brief_title>
  <official_title>Pilot Trial With Wormwood to Improve Appetite in Cancer, Autoimmune Diseases, Depression and Old Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Freiburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Freiburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany
      (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders
      such as old age, immune disorders and cancer.

      Trial aims at observing beneficial effects of wormwood supplementation in various chronic
      disorders associated with reduced appetite
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Supplementation with wormwood in chronic disorders associated with reduced appetite.

      Examples:

        1. Cancer

        2. Autoimmune diseases such as Crohns disease and IgA Nephropathy

        3. Old age

        4. Chronic stress and depression
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2006</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">August 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in appetite</measure>
    <time_frame>6-12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in quality of life</measure>
    <time_frame>12-24 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient with reduced appetite and reduced quality of life as a result of chronic
        progressive disorders such as cancer, autoimmune diseases (Crohn, IgA-Nephropathy), old age
        and depression
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Appetite and weight loss

          -  Chronic progressive disease

        Exclusion Criteria:

          -  Life expectancy less than 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simone S Krebs, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Freiburg, Nuclear Medicine, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Simone S Krebs, MD, Ph.D</last_name>
    <phone>(+49) -761-27-3913</phone>
    <email>simone.krebs@uniklinik-freiburg.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Freiburg, Medical Faculty</name>
      <address>
        <city>Freiburg</city>
        <state>Baden</state>
        <zip>79110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simone S Krebs, MD, PhD</last_name>
      <phone>(+49) -761-27-3913</phone>
      <email>simone.krebs@uniklinik-freiburg.de</email>
    </contact>
    <investigator>
      <last_name>Simone S Krebs, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Omer B, Krebs S, Omer H, Noor TO. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study. Phytomedicine. 2007 Feb;14(2-3):87-95. Epub 2007 Jan 19.</citation>
    <PMID>17240130</PMID>
  </reference>
  <reference>
    <citation>Krebs S, Omer TN, Omer B. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial. Phytomedicine. 2010 Apr;17(5):305-9. doi: 10.1016/j.phymed.2009.10.013. Epub 2009 Dec 3.</citation>
    <PMID>19962291</PMID>
  </reference>
  <verification_date>February 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2010</study_first_submitted>
  <study_first_submitted_qc>May 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2010</study_first_posted>
  <last_update_submitted>May 19, 2010</last_update_submitted>
  <last_update_submitted_qc>May 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Simone Krebs MD</name_title>
    <organization>Medical Faculty, University of Saarland, Homburg, Germany</organization>
  </responsible_party>
  <keyword>Crohn disease</keyword>
  <keyword>Involuntary weight loss in cancer</keyword>
  <keyword>IgA nephropathy</keyword>
  <keyword>Depression with reduced appetite</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

